Opportunities Preloader

Please Wait.....

News

CBR Pharma Insights (GlobalData)

Market Report Partner

2018-03-15
A Healthcare focused publishing brand operated and owned by GlobalData and closely aligned with GBI Research providing fully-referenced research reports in the Pharma industry ...

GlobalData completed it's acquisition of CBR Pharma in January 2019, all studies released since this date are listed under: GlobalData

 

CBR Pharma Insights reports are designed to empower readers to make better strategic decisions by providing incisive and timely analyses of key R&D, corporate, legislative and commercial issues and events shaping the industry and are prepared by a network of domain-specialists, analysts and ex-industry professionals.

 

CBR Pharma Insights features:

 

- Analyses include KOL opinion to provide more intuitive insights

- Rapid reaction to breaking issues and events that will shape the pharma industry

- Agile research approach to ensure each report project is assigned to the most appropriate analyst

- Consulting-style PowerPoint slide deck format - nothing but value-added content

 

Driven by key industry events & trends, i.e.:

 

- Regulatory Reform

- Strategies for Generics and Biosimilars

- New and Emerging Marketing Strategies

- Lifecycle Management

- The Payer Environment and Reimbursement

 

See and search within all CBR Pharma studies from the past 24 months

 

Contact us for time saving help

Back to news